PDB Short entry for 2G44 HEADER HORMONE/GROWTH FACTOR RECEPTOR 21-FEB-06 2G44 TITLE HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH TITLE 2 OBCP-1M-G AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX TITLE 3 II PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: GRIP PEPTIDE; COMPND 12 SYNONYM: NCOA-2, TRANSCRIPTIONAL INTERMEDIARY FACTOR 2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MCSG7 (PET12-DERIVATIVE); SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HOMO SAPIENS SOURCE 14 (HUMANS). KEYWDS ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.S.RAJAN,R.W.HSIEH,S.K.SHARMA,G.L.GREENE REVDAT 6 30-AUG-23 2G44 1 REMARK REVDAT 5 20-OCT-21 2G44 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2G44 1 VERSN REVDAT 3 24-FEB-09 2G44 1 VERSN REVDAT 2 16-JAN-07 2G44 1 JRNL REMARK MASTER REVDAT 1 09-JAN-07 2G44 0 JRNL AUTH R.W.HSIEH JRNL TITL DISCOVERY AND CHARACTERIZATION OF NOVEL ESTROGEN RECEPTOR JRNL TITL 2 AGONIST LIGANDS AND DEVELOPMENT OF BIOCHIPS FOR NUCLEAR JRNL TITL 3 RECEPTOR DRUG DISCOVERY JRNL REF THESIS 2006 JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 TITL IDENTIFICATION OF LIGANDS WITH BICYCLIC SCAFFOLDS PROVIDES REMARK 1 TITL 2 INSIGHTS INTO MECHANISMS OF ESTROGEN RECEPTOR SUBTYPE REMARK 1 TITL 3 SELECTIVITY REMARK 1 REF J.BIOL.CHEM. V. 281 17909 2006 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 16648639 REMARK 1 DOI 10.1074/JBC.M513684200 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 12934 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 675 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 REFLECTION IN BIN (WORKING SET) : 886 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.14 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 37 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3960 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 6 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.03000 REMARK 3 B22 (A**2) : 0.17000 REMARK 3 B33 (A**2) : -0.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.388 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.273 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 28.176 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4114 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5553 ; 1.132 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 486 ; 4.361 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;35.281 ;23.851 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 766 ;21.290 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;22.124 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 652 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2930 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2125 ; 0.257 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2814 ; 0.329 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 187 ; 0.193 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 75 ; 0.419 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.419 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2509 ; 1.900 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3967 ; 3.143 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1756 ; 2.093 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1586 ; 2.875 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 306 A 548 4 REMARK 3 1 B 306 B 548 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1890 ; 0.63 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1890 ; 0.57 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 688 C 696 4 REMARK 3 1 D 688 D 696 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 C (A): 70 ; 0.87 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 70 ; 0.66 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 305 A 548 REMARK 3 ORIGIN FOR THE GROUP (A): -12.3837 0.1993 -0.2425 REMARK 3 T TENSOR REMARK 3 T11: -0.0429 T22: -0.0910 REMARK 3 T33: -0.0188 T12: 0.0089 REMARK 3 T13: -0.0100 T23: 0.0177 REMARK 3 L TENSOR REMARK 3 L11: 0.8336 L22: 0.3048 REMARK 3 L33: 3.4673 L12: 0.3836 REMARK 3 L13: -0.6954 L23: 0.0144 REMARK 3 S TENSOR REMARK 3 S11: -0.0843 S12: 0.0828 S13: -0.0481 REMARK 3 S21: -0.0970 S22: -0.0064 S23: 0.0194 REMARK 3 S31: 0.0557 S32: 0.1010 S33: 0.0907 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 306 B 552 REMARK 3 ORIGIN FOR THE GROUP (A): -21.6258 -1.0783 23.4138 REMARK 3 T TENSOR REMARK 3 T11: -0.0358 T22: -0.0990 REMARK 3 T33: -0.0309 T12: -0.0029 REMARK 3 T13: -0.0263 T23: 0.0051 REMARK 3 L TENSOR REMARK 3 L11: 1.8384 L22: 0.3318 REMARK 3 L33: 2.1183 L12: 0.1923 REMARK 3 L13: -0.6492 L23: -0.0601 REMARK 3 S TENSOR REMARK 3 S11: -0.0117 S12: -0.0987 S13: -0.0253 REMARK 3 S21: -0.0030 S22: -0.0205 S23: 0.0823 REMARK 3 S31: 0.0716 S32: 0.1036 S33: 0.0322 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 688 C 696 REMARK 3 ORIGIN FOR THE GROUP (A): -11.2626 -18.5493 -8.0445 REMARK 3 T TENSOR REMARK 3 T11: 0.4567 T22: -0.3397 REMARK 3 T33: 0.0966 T12: 0.0691 REMARK 3 T13: 0.2786 T23: -0.0366 REMARK 3 L TENSOR REMARK 3 L11: 26.3603 L22: 13.5624 REMARK 3 L33: 16.7432 L12: 3.1181 REMARK 3 L13: 11.9485 L23: -10.8114 REMARK 3 S TENSOR REMARK 3 S11: -0.7739 S12: 0.8802 S13: -2.2344 REMARK 3 S21: -1.3883 S22: 0.1382 S23: 0.1553 REMARK 3 S31: 1.4179 S32: 0.3137 S33: 0.6358 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 688 D 696 REMARK 3 ORIGIN FOR THE GROUP (A): -35.4924 12.7199 26.2528 REMARK 3 T TENSOR REMARK 3 T11: 0.0121 T22: -0.3912 REMARK 3 T33: 0.2225 T12: 0.1745 REMARK 3 T13: 0.0005 T23: -0.0429 REMARK 3 L TENSOR REMARK 3 L11: 57.8812 L22: 17.0429 REMARK 3 L33: 39.5605 L12: 21.3591 REMARK 3 L13: 34.8898 L23: 24.0771 REMARK 3 S TENSOR REMARK 3 S11: 0.2222 S12: -1.4133 S13: 2.1867 REMARK 3 S21: 0.0835 S22: -1.5710 S23: 0.9220 REMARK 3 S31: -0.3234 S32: -2.1566 S33: 1.3488 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2G44 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000036663. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 77.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : BENT GE(111) MONOCHROMATOR REMARK 200 OPTICS : BENT CONICAL SI-MIRROR (RH REMARK 200 COATED) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14166 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.31400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.210 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1ZKY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE 0.1M TRIS PH 7.0 REMARK 280 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.95350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 LYS C 686 REMARK 465 HIS C 687 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 465 LYS D 686 REMARK 465 HIS D 687 REMARK 465 SER D 697 REMARK 465 SER D 698 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN D 695 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 333 C - N - CA ANGL. DEV. = 15.1 DEGREES REMARK 500 PRO B 333 C - N - CD ANGL. DEV. = -13.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 306 -17.73 -141.56 REMARK 500 GLU A 323 134.13 -31.87 REMARK 500 MET A 342 -74.56 -48.98 REMARK 500 GLU A 470 44.53 -90.54 REMARK 500 SER A 537 176.23 -57.21 REMARK 500 THR B 496 -176.20 -67.50 REMARK 500 ASN B 532 53.61 31.34 REMARK 500 ALA B 551 108.02 -163.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T3O A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T3O B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2G5O RELATED DB: PDB DBREF 2G44 A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 2G44 B 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 2G44 C 686 698 UNP Q15596 NCOA2_HUMAN 686 698 DBREF 2G44 D 686 698 UNP Q15596 NCOA2_HUMAN 686 698 SEQADV 2G44 CME A 381 UNP P03372 CYS 381 MODIFIED RESIDUE SEQADV 2G44 CME A 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 2G44 CME A 530 UNP P03372 CYS 530 MODIFIED RESIDUE SEQADV 2G44 SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 2G44 CME B 381 UNP P03372 CYS 381 MODIFIED RESIDUE SEQADV 2G44 CME B 417 UNP P03372 CYS 417 MODIFIED RESIDUE SEQADV 2G44 CME B 530 UNP P03372 CYS 530 MODIFIED RESIDUE SEQADV 2G44 SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 A 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 A 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 A 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 A 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 A 257 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 A 257 VAL HIS LEU LEU GLU CME ALA TRP LEU GLU ILE LEU MET SEQRES 8 A 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 A 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 A 257 GLY LYS CME VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 A 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 A 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 A 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 A 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 A 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 A 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 A 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CME LYS SEQRES 19 A 257 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 B 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 B 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 B 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 B 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 B 257 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 B 257 VAL HIS LEU LEU GLU CME ALA TRP LEU GLU ILE LEU MET SEQRES 8 B 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 B 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 B 257 GLY LYS CME VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 B 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 B 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 B 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 B 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 B 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 B 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 B 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CME LYS SEQRES 19 B 257 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER SEQRES 1 D 13 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SER MODRES 2G44 CME A 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G44 CME A 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G44 CME A 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G44 CME B 381 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G44 CME B 417 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2G44 CME B 530 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 381 16 HET CME A 417 10 HET CME A 530 10 HET CME B 381 16 HET CME B 417 10 HET CME B 530 10 HET T3O A 700 19 HET T3O B 701 19 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM T3O 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7- HETNAM 2 T3O EN-2-YL]PHENOL FORMUL 1 CME 6(C5 H11 N O3 S2) FORMUL 5 T3O 2(C17 H22 O2) FORMUL 7 HOH *6(H2 O) HELIX 1 1 THR A 311 GLU A 323 1 13 HELIX 2 2 SER A 338 LYS A 362 1 25 HELIX 3 3 GLY A 366 LEU A 370 5 5 HELIX 4 4 THR A 371 MET A 396 1 26 HELIX 5 5 ASN A 413 VAL A 418 5 6 HELIX 6 6 GLY A 420 ASN A 439 1 20 HELIX 7 7 GLN A 441 SER A 456 1 16 HELIX 8 8 GLY A 457 PHE A 461 5 5 HELIX 9 9 GLU A 470 ALA A 493 1 24 HELIX 10 10 THR A 496 LYS A 531 1 36 HELIX 11 11 SER A 537 ALA A 546 1 10 HELIX 12 12 HIS A 547 ARG A 548 5 2 HELIX 13 13 LEU B 306 LEU B 310 5 5 HELIX 14 14 THR B 311 GLU B 323 1 13 HELIX 15 15 SER B 338 LYS B 362 1 25 HELIX 16 16 THR B 371 SER B 395 1 25 HELIX 17 17 ASN B 413 LYS B 416 5 4 HELIX 18 18 MET B 421 ASN B 439 1 19 HELIX 19 19 GLN B 441 SER B 456 1 16 HELIX 20 20 LYS B 472 LYS B 492 1 21 HELIX 21 21 THR B 496 LYS B 531 1 36 HELIX 22 22 SER B 537 ALA B 546 1 10 HELIX 23 23 LYS C 688 GLN C 695 1 8 HELIX 24 24 LYS D 688 LEU D 694 1 7 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 LINK C GLU A 380 N CME A 381 1555 1555 1.33 LINK C CME A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 416 N CME A 417 1555 1555 1.33 LINK C CME A 417 N VAL A 418 1555 1555 1.33 LINK C LYS A 529 N CME A 530 1555 1555 1.33 LINK C CME A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N CME B 381 1555 1555 1.33 LINK C CME B 381 N ALA B 382 1555 1555 1.34 LINK C LYS B 416 N CME B 417 1555 1555 1.33 LINK C CME B 417 N VAL B 418 1555 1555 1.33 LINK C LYS B 529 N CME B 530 1555 1555 1.33 LINK C CME B 530 N LYS B 531 1555 1555 1.33 SITE 1 AC1 7 LEU A 346 THR A 347 GLU A 353 LEU A 384 SITE 2 AC1 7 LEU A 387 ARG A 394 ILE A 424 SITE 1 AC2 10 LEU B 346 THR B 347 GLU B 353 LEU B 384 SITE 2 AC2 10 MET B 388 ARG B 394 PHE B 404 ILE B 424 SITE 3 AC2 10 LEU B 428 LEU B 525 CRYST1 54.253 81.907 58.341 90.00 111.23 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018432 0.000000 0.007160 0.00000 SCALE2 0.000000 0.012209 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018389 0.00000